2022.

RNA-interference screen for p53 regulators unveils a role of WDR75 in ribosome biogenesis

Moudry P, Chroma K , Bursać S , Volarević S , Bartek J.

Cell Death and Differentiation - 687-696

https://www.nature.com/articles/s41418-021-00882-0

Q1

15.09.2020.

Dysregulated Ribosome Biogenesis Reveals Therapeutic Liabilities in Cancer

Slađana Bursać, Ylenia Prodan, Nick Pullen, Jiri Bartek, Siniša Volarević

Trends in Cancer - XX. 1-20

https://www.sciencedirect.com/science/article/pii/S2405803320302351

Q1

27.02.2020.

Cancer-associated mutations in the ribosomal protein L5 gene dysregulate the HDM2/p53-mediated ribosome biogenesis checkpoint

Oršolić I., Bursać S., Jurada D., Drmić Hofman I., Dembić Z., Bartek J., Mihalek I., Volarević S.

Oncogene - 39 3443–3457

Q1

12.02.2018.

Ribosome biogenesis in cancer: new players and therapeutic avenues

Pelletier J, Thomas G, Volarević S.

Nature Review Cancer - 18 51-63

Q1

02.01.2018.

Nucleolus as an emerging hub in maintenance of genome stability and cancer pathogenesis

Lindström M. S., Jurada D., Bursać S., Oršolić I., Bartek J.

Oncogene - 37 2351-2366

Q1

13.12.2017.

New insights into HEATR1 functions

Bursać S, Jurada D, Volarević S

Cell Cycle - 17 143-144

Q1

19.12.2016.

A regulatory module involving FGF13, miR-504 and p53 regulates ribosomal biogenesis and supports cancer cell survival

Bublik DR, Bursac S, Sheffer M, Orsolic I, Shalit T, Tarcic O, Kotler E, Mouhadeb O, Hoffman Y, Fuchs G, Levin Y, Volarevic S, Oren M

Proceedings of the National Academy of Sciences of the USA - 114 496-505

http://www.pnas.org/content/early/2016/12/13/1614876114

Q1

23.12.2015.

The relationship between the nucleolus and cancer: current evidence and emerging paradigms

Orsolic I, Jurada D, Pullen N, Oren M, Eliopoulos AG, Volarevic S.

Seminars in Cancer Biology - 37-38 36-50

http://www.sciencedirect.com/science/article/pii/S1044579X15300043

Q1

05.10.2015.

TPL2-NPM-p53 pathway monitors nucleolar stress

Eliopoulos AG, Volarevic S.

Oncoscience - 2 892–893

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4675775/pdf/oncoscience-02-0892.pdf

Q1

02.01.2015.

Exogenous BMP7 corrects plasma iron overload and bone loss in Bmp6-/- mice

Pauk M, Grgurevic L, Brkljacic J, Kufner V, Bordukalo-Niksic T, Grabusic K, Razdorov G, Rogic D, Zuvic M, Oppermann H, Babitt JL., Lin HJ,Volarevic S, Vukicevic S.

International Orthopaedics - 39 161-172

http://link.springer.com/article/10.1007/s00264-014-2550-4

Q2

19.08.2014.

p53 and ribosome biogenesis stress: The essentials

Golomb L,Volarevic S, Oren M.

FEBS letters - 588 2571-2579

http://onlinelibrary.wiley.com/doi/10.1016/j.febslet.2014.04.014/full

Q2

07.07.2014.

Physical and functional interaction of the TPL2 kinase with nucleophosmin

Kanellis DC, Bursac S, Tsichlis PN, Volarevic S, Eliopoulos AG.

Oncogene - 34 2516-2526

http://www.nature.com/onc/journal/v34/n19/full/onc2014183a.html

Q1

26.10.2013.

Activation of the tumor suppressor p53 upon impairment of ribosome biogenesis

Bursac S, Donati G, Brdovcak Cokaric M, Volarevic S.

Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease - 1842 817–830

http://www.sciencedirect.com/science/article/pii/S0925443913003062

Q1

14.07.2013.

Functional interplay between the DNA-damage-response kinase ATM and ARF tumour suppressor protein in human cancer

Velimezi G, Liontos M, Vougas K, Roumeliotis T, Bartkova J, Sideridou M, Dereli-Oz A, Kocylowski M, Pateras IS, Evangelou K, Kotsinas A, Orsolic I, Bursac S, Cokaric-Brdovcak M, Zoumpourlis V, Kletsas D, Papafotiou G, Klinakis A, Volarevic S, Gu W, Bartek J, Halazonetis TD, Gorgoulis VG.

Nature Cell Biology - 15 967-977

http://www.nature.com/ncb/journal/v15/n8/full/ncb2795.html

Q1

10.11.2012.

Mutual protection of ribosomal proteins L5 and L11 from degradation is essential for p53 activation upon ribosomal biogenesis stress

Bursac S, Brdovcak Cokaric M, Pfannkuchen M, Orsolic I, Golomb L, Zhu Y, Katz C, Daftuar L, Grabusic K, Vukelic I, Filic V, Oren M, Prives C, Volarevic S.

Proceedings of the National Academy of Sciences of the USA - 109 20467-20472

http://www.pnas.org/content/109/50/20467.abstract

Q1

27.01.2012.

Importin 7 and exportin 1 link c-Myc and p53 to regulation of ribosomal biogenesis

Golomb L, Bublik DR, Wilder S, Nevo R, Kiss V, Grabusic K, Volarević S, Oren M.

Molecular Cell - 45 222-232

http://www.sciencedirect.com/science/article/pii/S109727651100949X

Q1

26.12.2011.

Cdc6 expression represses E-cadherin transcription and activates adjacent replication origins

Sideridou M, Zakopoulou R, Evangelou K, Liontos M, Kotsinas A, Rampakakis E, Gagos S, Kahata K, Grabusic K, Gkouskou K, Trougakos IP, Kolettas E, Georgakilas AG, Volarevic S, Eliopoulos AG, Zannis-Hadjopoulos M, Moustakas A, Gorgoulis VG.

The Journal of Cell Biology - 195 1123-1140

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3246883/pdf/JCB_201108121.pdf

Q1

01.10.2011.

Natural killer T cells in pulmonary disorders

Rijavec M, Volarevic S, Osolnik K, Kosnik M, Korosec P.

Respiratory medicine - 105 S20-S25

http://www.resmedjournal.com/article/S0954-6111%2811%2970006-3/pdf

Q2

14.03.2011.

The balance between rRNA and ribosomal protein synthesis up-and downregulates the tumour suppressor p53 in mammalian cells

Donati G, Bertoni S, Brighenti E, Vici M, Treré D, Volarevic S, Montanaro L, Derenzini M.

Oncogene - 30 3274-3288

http://www.nature.com/onc/journal/v30/n29/full/onc201148a.html

Q1

07.05.2009.

PDK1 signaling in oocytes controls reproductive aging and lifespan by manipulating the survival of primordial follicles

Reddy P, Adhikari D, Zheng W, Liang S, Hämäläinen T, Tohonen V, Ogawa W, Noda T, Volarevic S, Huhtaniemi I, Liu K.

Human Molecular Genetics - 18 2813-2824

http://hmg.oxfordjournals.org/content/18/15/2813.full.pdf+html

Q1

09.03.2009.

The p53 tumor suppressor causes congenital malformations in Rpl24-deficient mice and promotes their survival

Barkic M, Crnomarkovic S, Grabusic K, Bogetic I, Panic L, Tamarut S, Cokaric M, Jeric I, Vidak S, Volarevic S.

Molecular and Cellular Biology - 29 2489-2504

http://mcb.asm.org/content/29/10/2489.full.pdf+html

Q1

15.01.2007.

S6-haploinsufficiency activates the p53 tumor suppressor

Panic L, Montagne J, Cokaric M, Volarevic S.

Cell Cycle - 6 20-24

http://www.tandfonline.com/doi/pdf/10.4161/cc.6.1.3666

Q2

25.09.2006.

Ribosomal protein S6 gene haploinsufficiency is associated with activation of a p53-dependent checkpoint during gastrulation

Panic L, Tamarut S, Sticker-Jantscheff M, Barkic M, Solter D, Uzelac M, Grabusic K, Volarevic S.

Molecular and Cellular Biology - 26 8880-8891

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1636830/

Q1

25.10.2005.

Inactivation of S6 ribosomal protein gene in T lymphocytes activates a p53-dependent checkpoint response

Sulic S, Panic L, Barkic M, Mercep M, Uzelac M, Volarevic S.

Genes & Development - 19 3070-3082

https://bib.irb.hr/datoteka/233137.genes_and_development.pdf

Q1

01.08.2005.

Deregulation of cell growth and malignant transformation

Sulic S, Panic L, Dikic I, Volarevic S.

Croatian Medical Journal - 46 622-638

http://neuron.mefst.hr/docs/CMJ/issues/2005/46/4/16100767.pdf

Q2

01.04.2005.

Compartmentalization of growth factor receptor signalling

Hoeller D, Volarevic S., Dikic I.

Current Opinion in Cell Biology - 17 107-111

http://www.sciencedirect.com/science/article/pii/S0955067405000074?np=y

Q1

20.08.2004.

A "continuous meeting" type of biomedical education in Rijeka

Volarević S.

Scandinavian Journal of Immunology - 60 324-326

http://onlinelibrary.wiley.com/doi/10.1111/j.0300-9475.2004.01381.x/epdf

Q2

16.03.2001.

CD45 is required for CD40-induced inhibition of DNA synthesis and regulation of c-Jun NH2-terminal kinase and p38 in BAL-17 B cells

Arimura Y, Ogimoto M, Mitomo K, Katagiri T, Yamamoto K, Volarevic S, Mizuno K, Yakura H.

Journal of Biological Chemistry - 276 8550-8556

http://www.jbc.org/content/276/11/8550.full

Q1

02.01.2001.

Role of S6 phosphorylation and S6 kinase in cell growth

Volarević S., Thomas G.

Progress in nucleic acid research and molecular biology - 65 101-127

http://www.ncbi.nlm.nih.gov/pubmed/11008486

Q4

16.06.2000.

Proliferation, but not growth, blocked by conditional deletion of 40S ribosomal protein S6

Volarevic S, Stewart MJ, Ledermann B, Zilberman F, Terracciano L, Montini E, Grompe M, Kozma SC, Thomas G.

Science - 288 2045-2047

http://science.sciencemag.org/content/288/5473/2045.long

Q1

01.03.1999.

Manipulating mammalian genome by gene targeting

Volarevic S, Pende M, Pullen N.

Croatian Medical Journal - 40 368-374

http://neuron.mefst.hr/docs/CMJ/issues/1999/40/3/10411964.pdf

Q2

01.04.1998.

Dominant negative variants of the SHP-2 tyrosine phosphatase inhibit prolactin activation of Jak2 (janus kinase 2) and induction of Stat5 (signal transducer and activator of transcription 5)-dependent transcription

Berchtold S, Volarevic S, Moriggl R, Mercep M, Groner B.

Molecular Endocrinology - 12 556-567

http://press.endocrine.org/doi/full/10.1210/mend.12.4.0086

Q1

01.04.1998.

Activation of STAT proteins and cytokine genes in human Th1 and Th2 cells generated in the absence of IL-12 and IL-4

Moriggl R, Kristofic C, Kinzel B, Volarevic S, Groner B, Brinkmann V.

The Journal of Immunology - 160 3385-3392

http://www.ncbi.nlm.nih.gov/pubmed/9531298

Q1

24.01.1997.

Evidence for different mechanisms of growth inhibition of T-cell lymphoma by phorbol esters and concanavalin A

Desrivieres S, Volarevic S, Mercep L, Ferrari S.

Journal of Biological Chemistry - 272 2470-2476

http://www.ncbi.nlm.nih.gov/pubmed/8999961

Q1

01.09.1992.

The CD45 tyrosine phosphatase regulates phosphotyrosine homeostasis and its loss reveals a novel pattern of late T cell receptor-induced Ca2+ oscillations

Volarevic S, Niklinska BB, Burns CM, Yamada H, June CH, Dumont FJ, Ashwell J.D.

The Journal of Experimental Medicine - 176 835-844

http://jem.rupress.org/content/176/3/835.full.pdf+html

Q1

01.09.1990.

Intimate association of Thy-1 and the T-cell antigen receptor with the CD45 tyrosine phosphatase

Volarevic S, Burns CM, Sussman J, Ashwell JD.

Proceedings of the National Academy of Sciences of the USA - 87 7085-7089

http://www.pnas.org/content/87/18/7085.full.pdf

Q1

02.01.1989.

The effect of physical exercise on lung diffusing capacity in patients with chronic obstructive lung disease

Volarevic S, Marusic M, Tocilj J, Dujic Z.

Plućne bolesti: Časopis Udruženja pneumoftiziologa Jugoslavije = The Journal of Yugoslav Association of Phthisiology and Pneumology - 41 42-45

http://www.ncbi.nlm.nih.gov/pubmed/2798571

2022.

Guyton i Hall: Medicinska fiziologija, 14. izdanje

Recenzent

Hall J, Hall M. (prevoditelji hrv. izdanja: Žižak, M, Dugandžić A, Lukinović - Škundar, V,)

Sveučilište u Zagrebu - Medicinski fakultet Zagreb

01.03.2018.

Stanična i molekularna imunologija

Recenzent

Abbas, Abul; Lichtman, Andrew; Pillai, Shiv;

Medicinska naklada

Batinić, Drago; Lukinović-Škudar, Vesna

Medicinska naklada Zagreb

16.05.2008.

Molekularna i stanična biologija tumora (Molecular and Cellular Biology of Tumors)

Autor poglavlja u knjizi

Volarević, Siniša; Đikić, Ivan

Interna medicina

Jakšić, Branimir ; Reiner, Željko ; Vucelić, Boris

Naklada Ljevak Zagreb

10.09.1990.

Aktivacija limfocita (Lymphocyte activation)

Autor poglavlja u knjizi

Volarević, Siniša

Imunološko prepoznavanje

Marušić, Matko

Medicinska naklada Zagreb

25.06.1990.

Prerada i predočivanje antigena (Antigen processing and presentation)

Autor poglavlja u knjizi

Merćep, Mladen; Volarević, Siniša

Imunološko prepoznavanje

Marušić, Matko

Medicinska naklada Zagreb

08.11.2024.

How do cell wih impaired ribosome production become maligant?

prof. dr. sc. Sinia Volarević

Zagreb (HDIR)

https://hdir-7.hdir.hr/

06.07.2023.

Crosstalk between ribosome biogenesis defects and p53 in disease pathogenesis

prof. dr. sc. Siniša Volarević

INSERM (Toulouse, Francuska)

08.07.2019.

Impaired ribosome biogenesis and diseases

prof.dr.sc. Siniša Volarević

Oxford Institute for Radiation Oncology, Oxford, Engleska

20.06.2019.

Impaired ribosome Biogenesis and Diseas

prof.dr.sc Siniša Volarević

Medils, Split

26.03.2019.

Uloga narušene kontrolne točke biogeneze ribosoma u supresiji tumora

Prof.dr.sc. Siniša Volarević

HAZU, Zagreb

28.09.2018.

The role of ribosomal proteins L5 and L11 in tumor supression

prof.dr.sc. Siniša Volarević

Hotel Valamar Koralj, Krk

28.09.2017.

The interplay between impaired ribosome biogenesis and p53

prof. dr. sc. Siniša Volarević

Bellvitge Biomedical Research Institute (IDIBELL), Barcelona,Španjolska

22.09.2017.

The role of ribosomal proteins L5 and L11 in tumor suppression - 7 hrvatski kongres hematologa

prof. dr. sc. Siniša volarević

Šibenik, Solaris

11.04.2017.

Pozvano predavanje od strane prof. dr. sc. Zlatka Dembića u sklopu kolegija Osnove imunoterapije tumora

prof. dr. sc. Siniša Volarević

KBC Rebro Zagreb

12.09.2016.

Monitoring ribosome biogenesis stress during develeopment and in cancer

prof. dr. sc. Siniša Volarević

Sveučilište u Ženevi, Ženeva , Švicarska

03.05.2016.

Monitoring ribosome biogenesis stress during development and in cancer

prof. dr. sc. Siniša Volarević

Karolinska Institute, Stockholm, Švedska

18.06.2014.

Ribosomal proteins and p53 activation

prof.dr.sc. Siniša Volarević

Medicinski fakultet Sveučilišta na Kreti, Kreta, Grčka

06.06.2011.

Regulation of p53 by ribosomal proteins

prof. dr. sc. Siniša Volarević

Columbia University, New York, SAD

20.01.2011.

Activation of a p53-dependent ribosome checkpoints responsible for congenital malformations in mice

prof.dr.sc. Siniša Volarević

Weizmann Institute of Science, Rehovot, Izrael

13.10.2010.

prof. dr. sc. Siniša Volarević

Klinička bolnica Golnik, Golnik, Slovenija

11.12.2009.

Regulation of the p53 tumor suppressor by ribosomal proteins

prof. dr. sc. Siniša Volarević

Institut za medicinsku genetiku, Ljubljana, Slovenija

16.11.2009.

prof. dr. sc. Siniša Volarević

Sveučilište u Beču, Beč, Austrija

05.04.2009.

prof. dr. sc. Siniša Volarević

Institute for Genetics of the University of Cologne, Koeln, Njemačka

25.04.2008.

prof. dr. sc. Siniša Volarević

National Cancer Institute, NCI, Bethesda, SAD

12.11.2007.

prof. dr. sc. Siniša Volarević

University of Umea, Umea, Švedska

08.06.2007.

prof. dr. sc. Siniša Volarević

Medicinski fakultet, Split, Hrvatska

05.03.2007.

prof. dr. sc. Siniša Volarević

University of Bologna, Bologna, Italija

06.11.2006.

prof. dr. sc. Siniša Volarević

Institut Ruđer Bošković, Zagreb

30.10.2006.

prof. dr. sc. Siniša Volarević

Institute Necker, Pariz, Francuska

09.11.2005.

prof. dr. sc. Siniša Volarević

Institute of Biochemistry II, Goethe University Medical School, Frankfurt am Main, Njemačka

01.09.2005.

prof. dr. sc. Siniša Volarević

Liječnički zbor, Mostar, Bosna i Hercegovina

17.05.2005.

prof. dr. sc. Siniša Volarević

Medicinski fakultet, Zagreb, Hrvatska

10.03.2005.

prof. dr. sc. Siniša Volarević

Prirodoslovno-matematički fakultet, Zagreb, Hrvatska

06.10.2004.

Conditional deletion of one S6 allele in T cells activates a p53-dependent checkpoint response

prof. dr. sc. Siniša Volarević

Institut Friedrich Miescher, Basel, Švicarska

07.09.2004.

S6 haploinsufficiency is associated with activation of a p53-dependent checkpoint during gastrulation

prof. dr. sc. Siniša Volarević

Sveučilište u Oslu, Oslo, Norveška

03.03.2003.

prof. dr. sc. Siniša Volarević

Institut Friedrich Miescher, Basel, Švicarska

23. studenoga 2012.

Biogenesis ribosomal stress and p53 activation

prof.dr.sc. Siniša Volarević

Sveučilište u Ženevi, Ženeva, Švicarska

2020.

Dysregulation of ribosome biogenesis in cancer

prof. dr. sc. Siniša Volarević

Usmeno

The first Dubrovnik Summer School of Patophysiology Dubrovnik

2020.

Ribosome biogenesis in cancer

prof. dr. sc. Siniša Volarević

Usmeno

Pozvano predavanje University of Oxford

20.06.2019.

Impaired ribosome biogenesis and diseas

Siniša Volarević

Usmeno

Advances in Biomedical Research III Medils, Split

26.03.2019.

Uloga narušene kontrolne točke biogeneze ribosoma u supresiji tumora

Prof.dr.sc. Siniša Volarević

Predavanje

Apoptoza i novotvorine HAZU Zagreb

27.09.2018.

The role of ribosomal proteins L5 and L11 in tumor supression

Predavanje

4th congress of Croatian genetics with international participation Krk

22.09.2017.

"The role of ribosomal proteins L5 and L11 in tumor suppression"

prof. dr. sc. Siniša Volarević

Predavanje

7. hrvatski kongres hematologa Solaris, Šibenik

08.06.2015.

"Ribosome biogenesis stress and p53 regulation"

prof. dr. sc. Siniša Volarević

predavanje

OMICs in Biomedical Research MEDILS - Mediterranean Institute For Life Sciences, Split, Hrvatska

06.11.2014.

"Ribosomal Biogenesis Stress and p53 Activation"

prof.dr.sc. Siniša Volarević

predavanje

HDIR-3; 3rd Meeting with International Participation "From Bench to Clinic"; Treća konferencija hrvatskog društva za istraživanje raka sa međunarodnim sudjelovanjem "Od bazičnih istraživanja do klinike" Zagreb, Hrvatska

26.06.2014.

"Ribosomal Biogenesis Stress and p53 Activation"

prof.dr.sc. Siniša Volarević

predavanje

Workshop „RNA biology meets Sleep and Circadian Rhythms“ University of Surrey, Guildford, Velika Britanija

23.04.2014.

"Ribosomal proteins and p53 activation"

prof.dr.sc. Siniša Volarević

predavanje

INsPiRE International Workshop on: Oncogenic Pathways and Antitumor Responses Atena, Grčka

10.10.2013.

"Ribosomal biogenesis stress and p53 activation"

prof. dr. sc. Siniša Volarević

predavanje

Nikola Škreb Symposium, Development and stem cells at the beginning of new millennium Medicinski fakultet Sveučilišta u Zagrebu, Zagreb, Hrvatska

13.09.2013.

"Response of mammalian cells to impairment of ribosome biogenesis"

prof.dr.sc. Siniša Volarević

predavanje

3rd Congress of Croatian Physiological Society and 1st Regional Congress of the Physiological Societies University of Rijeka, Faculty of Civil Engineering, University Campus, Rijeka, Hrvatska

26.09.2012.

"Response of mammalian cells to ribosomal stress"

prof. dr. sc. Siniša Volarević

predavanje

XXII Symposium EPNC (Electromagnetic Phenomena in Nonlinear Circuits) Pula, Hrvatska

25.09.2012.

"Ribosomal Biogenesis Stress and p53 Activation"

prof. dr. sc. Siniša Volarević

predavanje

2nd Inflammation, Cancer and Novel Therapeutics Conference & Summer School 2012. Malia - Kreta, Grčka

24.09.2012.

"Defects in ribosome biogenesis and diseases"

prof. dr. sc. Siniša Volarević

predavanje

4th INFLA-CARE Annual Meeting Malia - Kreta, Grčka

20.05.2012.

"The effect of iron on bone and plasma bone morphogenetic proteins"

Pauk, M.; Grabusic, K.; Grgurevic, L.; Brkljacic, J.; Rogic, D.; Babbit, JL.; Lin, HY. ; Volarevic, S.; Oppermann, H.; Vukicevic, S.

European Calcified Tissue Society - ECTS 2012, 39th Annual Congress Stockholm, Švedska

17.02.2012.

"Ribosomal proteins and p53 regulation"

prof. dr. sc. Siniša Volarević

predavanje

FEBS 3 + Meeting - "From molecules to life and back" Opatija, Hrvatska

10.10.2011.

“Genetic manipulation of ribosome biogenesis in inflammation-driven liver cancer”

prof. dr. sc. Siniša Volarević

predavanje

3rd INFLA-CARE Annual meeting Atena, Grčka

29.05.2011.

"Regulation of the p53 Tumor Suppressor by Ribosomal Proteins"

prof. dr. sc. Siniša Volarević

predavanje

From Ruđer Bošković to Today: Contribution of Croatian Scientists to the World Scientific Heritage Dubrovnik, Hrvatska

15.04.2011.

Regulation of p53 by Ribosomal Stress

prof. dr. sc. Siniša Volarević

predavanje

Advances in Immunology and Cancer Biology - Scientific Workshop Bogazici University, Istanbul, Turska

01.10.2010.

“Ribosomi i bolesti”

prof. dr. sc. Siniša Volarević

predavanje

391st colloqium of Croatian Society of Biochemistry and Molecular Biology & Croatian Chemical Society Rijeka&Istra / 391. kolokvij HDBMB-a i HKD-a Rijeke i Istre Rijeka, Hrvatska

28.09.2010.

"Ribosome networks in carcinogenesis"

prof. dr. sc. Siniša Volarević

predavanje

2nd INFLA-CARE Annual meeting and 1st Inflammation & Cancer Summer School 2010 Kreta, Grčka

16.09.2010.

"The role of a ribosomal biogenesis - p53 checkpoint in the pathogenesis of malignant tumors and congenital malformations"

prof. dr. sc. Siniša Volarević

plenarno predavanje

HDBMB2010 - 10th Congress of the Croatian Society of Biochemistry and Molecular Biology „The Secret Life of Biomolecules” Opatija, Hrvatska

15.09.2010.

"Ribosome and diseases"

Volarević S., Grabušić K., Barkić M., Bursać S., Oršolić I.

predavanje

6th Croatian Congress of Pharmacology with International Participation; Symposium: Molecular Mechanism of Diseases and Future Therapies Opatija, Hrvatska

11.09.2010.

"Regulation of the p53 tumour suppressor by ribosomal proteins"

prof. dr. sc. Siniša Volarević

predavanje

EMBO Practical Course „Anatomy and Embryology of the Mouse” Medicinski fakultet Sveučilišta u Splitu, Split, Hrvatska

08.09.2010.

"Activation of a p53dependent ribosome checkpoint is responsible for congenital malformations in mice"

prof. dr. sc. Siniša Volarević

plenarno predavanje

5th Central European Conference „Chemistry Towards Biology” Primošten, Hrvatska

20.07.2010.

“Regulation of p53 by ribosomal proteins in cancer”

prof. dr. sc. Siniša Volarević

predavanje

TransMedRi - Kick-off Meeting (FP7 REGPOT 2010-5) Medicinski fakultet Sveučilišta u Rijeci, Rijeka, Hrvatska

15.04.2010.

"Primjer uspješnog projekta COOPERATION / HEALTH"

prof. dr. sc. Siniša Volarević

predavanje

Info dan „FP7 Health & IMI programi” Institut Ruđer Bošković, Zagreb, Hrvatska

25.03.2010.

5th Croatian Oncology Conference / V. hrvatski onkološki kongres Dubrovnik-Cavtat, Hrvatska

15.06.2009.

"Regulation of the p53 tumor suppressor by ribosomal proteins"

prof. dr. sc. Siniša Volarević

predavanje

EMBO Young Scientists Forum Sveučilište u Zagrebu, Zagreb, Hrvatska

14.05.2009.

"Regulation of the p53 tumor suppressor by ribosomal proteins"

prof. dr. sc. Siniša Volarević

predavanje

8th Balkan Meeting on Human Genetics (8BMHG) Cavtat, Hrvatska

06.04.2009.

Signaling pathways in inflamation-associated cancer

prof. dr. sc. Siniša Volarević

predavanje

INFLA-CARE Kick-off Meeting Sveučilište u Koeln-u, Institute of Genetics; Koeln, Njemačka

20.11.2008.

"Sniženi izražaj ribosomalnih proteina uzrokuje p53-ovisne patološke promjene"

prof. dr. sc. Siniša Volarević

plenarno predavanje

50 Years of Molecular Biology in Croatia / 50 godina molekularne biologije u Hrvatskoj Zagreb, Hrvatska

06.09.2008.

"The p53 tumor suppressor permits survival of ribosomal protein L24-deficient mice at the expense of malformations"

Barkić M., Crnomarković S., Volarević S.

EMBO Practical Course: „Anatomy and Embryology of the Mouse” Zagreb, Hrvatska

17.06.2008.

"Pogreške u sintezi ribosomalnih proteina uzrokuju p53-ovisne poremećaje embrionalnog razvoja"

prof. dr. sc. Siniša Volarević

predavanje

Coloqium of Department of Molecular Biology / Kolokvij Zavoda za molekularnu biologiju Institut Ruđer Bošković, Zagreb, Hrvatska

2008.

Info day for FP7 priority „Health”, Zagreb, Croatia

09.09.2007.

5th Croatian Congress of Pharmacology and 2nd Congress of Croatian Physiological Society / 5. Hrvatski kongres farmakologije i 2. kongres Hrvatskog društva fiziologa, s međunarodnim sudjelovanjem Osijek, Hrvatska

29.01.2007.

International Centre for Genetic Engineering and Biotechnology, Area Science Park, Trst, Italija

03.10.2006.

"Ribosomal protein S6 haploinsufficiency activates a p53-dependent checkpoint during gastrulation"

prof. dr. sc. Siniša Volarević

predavanje

Congress of Croatian Society of Biochemistry and Molecular Biology Vodice, Hrvatska

24.09.2006.

"Ribosomal protein S6 haploinsufficiency activates a p53-dependent checkpoint during gastrulation"

prof. dr. sc. Siniša Volarević

plenarno predavanje

9th Croatian Biological Congress with International Participation - Croatian Biological Society / 9. Hrvatski Biološki Kongres s međunarodnim sudjelovanjem - Hrvatsko biološko društvo 1885 Rovinj, Hrvatska

09.09.2006.

"Nascent ribosome biogenesis is required during cell growth"

prof. dr. sc. Siniša Volarević

predavanje

EMBO Practical Course: „Anatomy and Embryology of the Mouse” Zagreb, Hrvatska

28.07.2006.

Centre de Génétique Moléculaire - University of Paris, Gif-sur-Yvette Cedex, Francuska

30.06.2006.

"S6-Haploinsufficiency Activates the p53 Tumor Suppressor in Mice"

prof. dr. sc. Siniša Volarević

predavanje

The 19th Biennial Meeting of the European Association of Cancer Research, EACR-19 Budimpešta, Mađarska

25.05.2006.

"Inactivation of S6 ribosomal protein gene in T lymphocytes activates a p53-dependent checkpoint response"

prof. dr. sc. Siniša Volarević

predavanje

The Immunologic Signaling Conference - ImmS 2006: From Molecular to Theoretical Networks: Intra - and Extracellullar Immunologic Signals" Dubrovnik, Hrvatska

14.10.2005.

"Biološki odgovor stanica sisavaca na pogrešku u sintezi ribosoma"

prof. dr. sc. Siniša Volarević

predavanje

359th colloqium of Croatian Society of Biochemistry and Molecular Biology, Croatian Society of Chemical Engineers and Croatian Society of Chemistry - Rijeka branch / 359. kolokvij HDBMB, HDKI i HDK - podružnica Rijeka Rijeka, Hrvatska

25.09.2005.

"The response of mammalian cells to a defect in ribosome biogenesis"

prof. dr. sc. Siniša Volarević

predavanje

2nd Congress of Croatian Geneticists with International Participation / 2. Kongres Hrvatskog Genetičkog društva Supetar, Hrvatska

08.10.2004.

"The role of ribosome biogenesis in regulation of cell growth and cell division"

prof. dr. sc. Siniša Volarević

predavanje

Annual Meeting 2004, Croatian Immunological Society / 2004 Godišnji sastanak Hrvatskog Imunološkog Društva Opatija, Hrvatska

14.09.2004.

"Activation of a p53-dependent checkpoint response by inactivation of one S6 allele during gastrulation"

prof. dr. sc. Siniša Volarević

predavanje

4th Croatian Congress of Pharmacology with International Participation / Četvrti hrvatski kongres farmakologije s međunarodnim učešćem Split, Hrvatska

01.09.2003.

"Conditional deletion of S6 ribosomal protein gene by CD4 Cre transgene"

Šulić S., Panić, L.; Volarević S.

poster

3rd Conference - European-American School in Forencis Genetics and Mayo Clinic Course in Advanved Molecular and Cellular Medicine Zagreb, Hrvatska

09.09.2002.

"Potential role of CD26 in coeliac disease"

Detel Bisić D., Volarević S., Peršić M., Varljen J.

poster

1st Croatian Congress on Molecular Life Science - 1st CCOMLIS Opatija, Hrvatska

15.10.2001.

EMBO Lecture Course : Cellular Signalling in development and disease Split, Hrvatska

19.09.2001.

"Proliferation, but not growth, blocked by conditional deletion of 40S ribosomal protein S6"

prof. dr. sc. Siniša Volarević

predavanje

3rd Croatian Congress of Pharmacology with International Participation / Treći hrvatski kongres farmakologije s međunarodnim učešćem Zagreb, Hrvatska,

01.10.2014. -

Uloga supresora tumora p53 u regulaciji homeostaze proteina u stanicama heterozigotnima za gen ribosomski protein L24

Deana Jurada Doctorate

Poslijediplomski sveučilišni (doktorski) studij Biomedicina

15.06.2013. - 30.08.2017.

Uloga somatskih mutacija gena za ribosomske proteine L5 i L11 u patogenezi zločudnih tumora

Ines Oršolić Doctorate

Poslijediplomski sveučilišni (doktorski) studij Biomedicina

Date of degree: 30.08.2017.

29.12.2006. - 09.09.2013.

Uloga ribosomskih proteina u aktivaciji supresora tumora p53

Slađana Bursać Doctorate

Poslijediplomski sveučilišni (doktorski) studij Biomedicina

Date of degree: 09. 09. 2013.

29.05.2006. - 10.02.2014.

Mehanizmi putem kojih supresor tumora p53 uzrokuje patološki fenotip Rpl24-heterozigotnih miševa

Maja Cokarić Brdovčak Doctorate

Poslijediplomski sveučilišni (doktorski) studij Biomedicina

Date of degree: 10. 02. 2014.

- 23. 05. 2005.

Specifična inaktivacija ribosomskog proteina S6 u limfocitima T in vivo

Sanda Tamarut Master's Degree

Poslijediplomski studij biologije

Date of degree: 23.05.2005.

01.12.2002. - 30.11.2010.

Uloga tumorskog supresora p53 u fenotipu Rpl24 heterozigotnih miševa

Martina Barkić Doctorate

Poslijediplomski sveučilišni (doktorski) studij Biomedicina

Date of degree: 30. 11. 2010.

17.09.2018. -

Uloga heterozigotnosti gena za ribosomki protein S6 u zloćudnoj preobrazbi stanica

Ylenia Prodan Doctorate

Poslijediplomski sveučilišni (doktorski) studij Biomedicina

- 30. 09. 2005.

Utjecaj sinteze ribosomskog proteina S6 na embrionalni razvoj miša

Linda Panić Master's Degree

Poslijediplomski studij biologije

Date of degree: 30. 09. 2005.

17.06.2019. - 22.06.2019.

Impaired ribosome Biogenesis and Disease

Split, Hrvatska Pozvani predavač

17.10.2017. - 20.10.2017.

EMBO - The EMBO members meeting

Heidelberg, Njemačka sudionik

23.05.2013. - 25.05.2013.

Workshop: Live Cell Imaging Microscopy

Rijeka (Medicinski fakultet Sveučilišta u Rijeci) organizator (u sklopu projekta FP7 REGPOT - TransMedRi)

13.09.2012. - 15.09.2012.

Workshop: Cell Proliferation in Cancer

Rijeka (Medicinski fakultet Sveučilišta u Rijeci) organizator (u sklopu projekta FP7 REGPOT - TransMedRi)

10.10.2011. - 11.10.2011.

Workshop: Translational Cancer Research

Rijeka (Medicinski fakultet Sveučilišta u Rijeci) organizator (u sklopu projekta FP7 REGPOT -TransMedRi)

15.09.2010. - 18.09.2010.

6. kongres farmakologije s međunarodnim sudjelovanjem Simpozij: Molecular Basis of Diseases

Opatija organizator simpozija

20.07.2010. -

Inicijalni sastanak FP7 REGPOT - TransMedRi

Rijeka (Medicinski fakultet Sveučilišta u Rijeci) suorganizator

21.05.2009. - 23.05.2009.

Početni tečaj za mlade kliničare i specijalizante: Metode molekularne biologije

Rijeka (Zavod za molekularnu medicinu i biotehnologiju, Medicinski fakultet u Sveučilišta Rijeci) organizator

2020.

Translational Oncology

https://www.journals.elsevier.com/translational-oncology/editorial-board

2022.

Medicinska fiziologija - 14 izdanje

01.11.2017.

Abbas, A., Lichtman, A., Pillai, S., Stanična i molekularna imunologija, Medicinska naklada, Zagreb, 2018.

2001. - 2016.

Recenzent brojnih međunarodnih znanstvenih časopisa (Genes and Development, Oncogene, Oncotarget, PloS Genetics, Nature Medicine, Journal of Biological Chemistry, Molecular Cellular Biology, American Journal of Pathology, FEBS Letters, Croatian Medical Journal, Pharmacology & Therapeutics, Cell Death & Differentiation, itd.)

2024. - 2025.

UNIRI projekti iskusnih znanstvenika: Uloga poremećaja sinteze proteina u zloćudnoj preobrazbi stanica heterozigotnih za ribosomski protein S6

Voditelj projekta

Sveučilište u Rijeci 7.339,96 eur

26.12.2023. - 25.12.2027.

Međudjelovanje heterozigotne mutacije gena za ribosomski protein L24 i p53 u patogenezi bolesti

Voditelj projekta

Hrvatska zaklada za znanost 199.084,20 eur

2022. - 2026.

COST action, title:Translational control in cancer European Network

Suradnik na projektu

EU

2019. - 2023.

Karakterizacija mehanizama putem kojih heterozigotna mutacija ribosomskog proteina l24 uzrokuje patološki fenotiop u miša

Voditelj projekta

Sveučilište u Rijeci 228.000,00 kn

02.11.2017. -

ZCI -Reproduktivna i regenerativna medicina - istraživanja novih platformi i potencijala

Partner na projektu

MZO 1.899.992,00 kn

08.05.2017. -

Uloga heterozigotnosti gena za ribosomski protein S6 u zločudnoj preobrazbi stanica

Voditelj projekta

Hrvatska zaklada za znanost Ukupna ugovorena vrijednost: 1.000.000,00 kn

01.12.2012. - 01.12.2015.

Uloga ribosomskih proteina L5 i L11 u aktivaciji tumor supresora p53 i patogenezi zloćudnih tumora; The Role of Ribosomal Proteins L5 and L11 in Tumor Suppression

voditelj projekta

Hrvatska zaklada za znanost Ukupna ugovorena vrijednost: 1.350.000,00 kn

01.07.2010. - 30.06.2013.

TransMedRi - Upgrading the capacities for research in translational medicine at the Faculty of Medicine University of Rijeka

voditelj dijela projekta iz područja onkologije - WP2

European Commission (REGPOT FP7) Ukupna ugovorena vrijednost za WP2: 517.920,00 EUR; Ukupna ugovorena vrijednost za Sveučilište u Rijeci, Medicinski fakultet: 2.332.109,20 EUR

http://transmedri.uniri.hr/index.php?option=com_content&view=article&id=3&Itemid=16

01.02.2010. - 30.07.2011.

Proizvodnja monoklonskih protutijela protiv ribosomalnih proteina (nastavak projekta)

voditelj projekta

Hrvatski institut za tehnologiju, MZOŠ Ukupna ugovorena vrijednost: 1.280.000,00 kn

01.02.2009. - 01.02.2011.

Regulacija tumor supresora p53 ribosomalnim proteinima u fiziološkim i patološkim uvjetima; Regulation of the p53 Tumor Suppressor by Ribosomal Proteins in Physiological and Pathological Conditions

voditelj projekta

Unity Through Knowledge Fund, MZOŠ Ukupna ugovorena vrijednost: 1.430.210,80 kn

http://www.ukf.hr/default.aspx?id=18&projectid=216&prikaz=1

2009. - 30.06.2013.

INFLA CARE - Inflammation-associated Tumorigensis for the Rational Design of Novel Anti-cancer Therapeutic Strategies; Razumijevanje nastajanja tumora povezanih s upalom s ciljem racionalnog stvaranja novih terapeutskih strategija protiv zloćudnih tumora

voditelj dijela projekta koji se odnosi na korisnika-partnera: Sveučilište u Rijeci, Medicinski fakultet)

European Commission (FP7, SP1- Cooperation, Collaborative project, Large-scale integrating project) Ukupna vrijednost za korisnika-partnera Sveučilište u Rijeci, Medicinski fakultet: 641.618,91 EUR

http://inflacare.imbb.forth.gr/index.php

2007. - 31.12.2013.

Odgovor stanica sisavaca na pogrešku u sintezi ribosoma in vivo

voditelj projekta

MZOŠ Ukupna vrijednost: 1.159.998,43 kn

28.06.2006. - 28.06.2009.

Proizvodnja monoklonskih protutijela protiv ribosomalnih proteina miša i čovjeka

voditelj projekta

Hrvatski institut za tehnologiju, MZOŠ Ukupna ugovorena vrijednost: 1.754.000,00 kn

01.07.2002. - 01.07.2006.

Odnos strukture i funkcije tirozinske fosfataze CD45 (0062071)

voditelj projekta

MZOŠ Ukupna ugovorena vrijednost: 1.160.000,00 kn

03.09.2001. - 03.09.2002.

Odnos strukture i funkcije tirozinske fosfataze CD45 (062102)

voditelj projekta

MZOŠ Ukupna ugovorena vrijednost: 60.000,00 kn

2001. - 31.03.2004.

The Role of Ribosome Biogenesis in Cell Cycle Progression

voditelj projekta

Swiss National Science Foundation (SCOPES PROGRAM)